Delaware Health Info Network to Use Clinical Specimens for Medical Research | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Delaware Health Info Network to Use Clinical Specimens for Medical Research

October 22, 2015
by Rajiv Leventhal
| Reprints

The Delaware Health Information Network (DHIN) has announced a collaboration with the Lexington, Mass.-based biospecimen collection company iSpecimen that will allow hospitals and labs in the DHIN network to repurpose remnant clinical specimens into medical research programs.

The specimens involved are samples that would otherwise be discarded once patient testing is complete, officials said in a joint announcement on the partnership. The organizations also announced Maryland-based Union Hospital as the first DHIN member to participate in the joint program.

Through this program, healthcare information from participating DHIN members is de-identified and matched to corresponding remnant specimens at these provider sites. The specimens and their data are then searchable in real-time using iSpecimen's technology. When matches are made, iSpecimen's technology instructs laboratory personnel at participating provider sites to pick and ship the specimens to iSpecimen's research customers instead of discarding them as they usually do once clinical testing is complete. Hospitals choosing to take part in the program make a critically important contribution to the acceleration of biomedical research and also benefit from reduced DHIN fees, which may be put back into hospital operations, according to officials.

Officials point out that the patient has a central role in this program. Only samples from patients who have expressly consented to participate are considered for an active research project. All samples from patients who have not provided consent are excluded and suppressed from consideration.

The value of digitizing medical data extends beyond the obvious value of supporting direct patient care," Jan Lee, M.D., CEO, DHIN, said in a statement. "With informed patient consent, digital data can also help match clinical specimens with very specific research criteria. DHIN is proud to play a role in supporting such efforts to find new breakthrough treatments and cures. We are delighted to have iSpecimen as a technology partner and to have Union Hospital as the first adopter of this innovative program."

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

ONC Roundup: Senior Leadership Changes Spark Questions

The Office of the National Coordinator for Health IT (ONC) has continued to experience changes within its upper leadership, leading some folks to again ponder what the health IT agency’s role will be moving forward.

Media Report: Walmart Hires Former Humana Executive to Run Health Unit

Reigniting speculation that Walmart and insurer Humana are exploring ways to forge a closer partnership, Walmart Inc. has hired a Humana veteran to run its health care business, according to a report from Bloomberg.

Value-Based Care Shift Has Halted, Study Finds

A new study of 451 physicians and health plan executives suggests that progress toward value-based care has stalled. In fact, it may have even taken a step backward over the past year, the research revealed.

Study: EHRs Tied with Lower Hospital Mortality, But Only After Systems Have Matured

Over the past decade, there has been significant national investment in electronic health record (EHR) systems at U.S. hospitals, which was expected to result in improved quality and efficiency of care. However, evidence linking EHR adoption to better care is mixed, according to medical researchers.

Nursing Notes Can Help Predict ICU Survival, Study Finds

Researchers at the University of Waterloo in Ontario have found that sentiments in healthcare providers’ nursing notes can be good indicators of whether intensive care unit (ICU) patients will survive.

Health Catalyst Completes Acquisition of HIE Technology Company Medicity

Salt Lake City-based Health Catalyst, a data analytics company, has completed its acquisition of Medicity, a developer of health information exchange (HIE) technology, and the deal adds data exchange capabilities to Health Catalyst’s data, analytics and decision support solutions.